Bio-Techne Corp (TECH)
62.63 -1.52 (-2.37%) 11:33 ET [NASDAQ]
62.62 x 7 62.79 x 100
Realtime by (Cboe BZX)
62.62 x 7 62.79 x 100
Realtime - - (-) -
for Thu, Feb 27th, 2025
Results
download Want to compare other data? Select FieldsSymbol | TECH | SRPT | PCVX | ||
Company | Bio-Techne Corp | Sarepta Therapeutics | Vaxcyte Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 63.73 | 101.00 | 77.87 | ||
High | 64.42 | 109.50 | 78.75 | ||
Low | 61.29 | 101.00 | 76.15 | ||
Last | 62.63 | 108.18 | 76.33 | ||
Change | -1.52 | +1.32 | -2.32 | ||
% Change | -2.37% | +1.24% | -2.95% | ||
Volume | 563,456 | 403,678 | 274,172 | ||
20-Day Average Volume | 1,627,951 | 766,284 | 923,176 | ||
Previous Close | 64.15 | 106.86 | 78.65 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 68.49 | 110.16 | 84.30 | ||
20-Day Raw Stochastic | 3.79% | 36.43% | 2.95% | ||
20-Day Relative Strength | 30.78% | 41.23% | 37.52% | ||
Weighted Alpha | -21.91 | -26.16 | -15.33 | ||
Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 16% Buy | 100% Sell | 8% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -5.27% since 02/20/25 | -0.43% since 02/20/25 | -7.08% since 02/20/25 | ||
Low | 61.36 on 02/27/25 | 101.00 on 02/27/25 | 76.15 on 02/27/25 | ||
High | 66.87 on 02/21/25 | 110.00 on 02/21/25 | 84.01 on 02/21/25 | ||
1-Month | |||||
%Chg | -18.85% since 01/27/25 | -7.66% since 01/27/25 | -15.70% since 01/27/25 | ||
Low | 61.36 on 02/27/25 | 101.00 on 02/27/25 | 76.15 on 02/27/25 | ||
High | 79.28 on 02/05/25 | 120.05 on 02/05/25 | 93.77 on 01/28/25 | ||
3-Month | |||||
%Chg | -17.70% since 11/27/24 | -21.75% since 11/27/24 | -18.46% since 11/27/24 | ||
Low | 61.36 on 02/27/25 | 101.00 on 02/27/25 | 76.15 on 02/27/25 | ||
High | 79.28 on 02/05/25 | 138.81 on 11/29/24 | 94.76 on 12/02/24 | ||
6-Month | |||||
%Chg | -12.66% since 08/27/24 | -23.26% since 08/27/24 | -2.72% since 08/27/24 | ||
Low | 61.36 on 02/27/25 | 101.00 on 02/27/25 | 76.15 on 02/27/25 | ||
High | 80.95 on 09/19/24 | 140.97 on 08/28/24 | 121.06 on 09/19/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 10,141,345 | 10,207,266 | 9,802,701 | ||
Shares Outstanding, K | 158,088 | 95,520 | 124,637 | ||
Annual Sales | 1,159,060,000 | 1,243,340,000 | 0 | ||
Annual Net Income | 168,110,000 | -535,980,000 | -402,270,000 | ||
Last Quarter Sales | 297,030,000 | 467,170,000 | 0 | ||
Last Quarter Net Income | 34,890,000 | 33,610,000 | -103,120,000 | ||
60-Month Beta | 1.27 | 0.75 | 0.98 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.42 on 02/05/25 | 1.90 on 02/26/25 | -1.12 on 02/25/25 | ||
Latest Earnings Date | 02/05/25 | 02/26/25 | 02/25/25 | ||
Most Recent Dividend | 0.080 on 11/08/24 | N/A | N/A | ||
Next Ex-Dividends Date | 11/08/24 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 38.92 | 92.20 | 0.00 |